Pacific Center for Financial Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $235K | Sell |
935
-89
| -9% | -$19.1K | 0.05% | 86 |
|
|
2026
Q1 | $223K | Sell |
1,024
-211
| -17% | -$46.8K | 0.06% | 88 |
|
|
2025
Q4 | $286K | Hold |
1,235
| – | – | 0.07% | 79 |
|
|
2025
Q3 | $286K | Hold |
1,235
| – | – | 0.07% | 79 |
|
|
2025
Q2 | $229K | Hold |
1,235
| – | – | 0.06% | 88 |
|
|
2025
Q1 | $259K | Sell |
1,235
-1,601
| -56% | -$311K | 0.07% | 79 |
|
|
2024
Q4 | $504K | Buy |
2,836
+208
| +8% | +$38.2K | 0.13% | 47 |
|
|
2024
Q3 | $519K | Buy |
2,628
+12
| +0.5% | +$2.24K | 0.14% | 47 |
|
|
2024
Q2 | $449K | Buy |
2,616
+15
| +0.6% | +$2.48K | 0.13% | 49 |
|
|
2024
Q1 | $474K | Buy |
2,601
+13
| +0.5% | +$2.24K | 0.14% | 47 |
|
|
2023
Q4 | $401K | Buy |
2,588
+16
| +0.6% | +$2.33K | 0.13% | 49 |
|
|
2023
Q3 | $383K | Buy |
2,572
+14
| +0.5% | +$2.06K | 0.13% | 49 |
|
|
2023
Q2 | $345K | Buy |
2,558
+15
| +0.6% | +$2.2K | 0.11% | 59 |
|
|
2023
Q1 | $405K | Buy |
+2,543
| New | +$389K | 0.14% | 51 |
|
|
2022
Q3 | $338K | Buy |
2,516
+14
| +0.6% | +$2.01K | 0.13% | 53 |
|
|
2022
Q2 | $383K | Buy |
2,502
+1,063
| +74% | +$162K | 0.16% | 49 |
|
|
2022
Q1 | $233K | Hold |
1,439
| – | – | 0.08% | 68 |
|
|
2021
Q4 | $195K | Buy |
1,439
+6
| +0.4% | +$709 | 0.08% | 75 |
|
|
2021
Q3 | $155K | Buy |
1,433
+498
| +53% | +$56.9K | 0.07% | 80 |
|
|
2021
Q2 | $105K | Hold |
935
| – | – | 0.05% | 109 |
|
|
2021
Q1 | $101K | Hold |
935
| – | – | 0.05% | 106 |
|
|
2020
Q4 | $100K | Buy |
935
+111
| +13% | +$10.7K | 0.04% | 103 |
|
|
2020
Q3 | $72K | Hold |
824
| – | – | 0.03% | 102 |
|
|
2020
Q2 | $81K | Buy |
824
+454
| +123% | +$40K | 0.04% | 94 |
|
|
2020
Q1 | $28K | Hold |
370
| – | – | 0.02% | 134 |
|
|
2019
Q4 | $33K | Hold |
370
| – | – | 0.01% | 144 |
|
|
2019
Q3 | $28K | Hold |
370
| – | – | 0.01% | 153 |
|
|
2019
Q2 | $27K | Hold |
370
| – | – | 0.01% | 148 |
|
|
2019
Q1 | $30K | Hold |
370
| – | – | 0.02% | 135 |
|
|
2018
Q4 | $34K | Hold |
370
| – | – | 0.02% | 125 |
|
|
2018
Q3 | $35K | Hold |
370
| – | – | 0.02% | 134 |
|
|
2018
Q2 | $34K | Hold |
370
| – | – | 0.02% | 123 |
|
|
2018
Q1 | $35K | Hold |
370
| – | – | 0.02% | 117 |
|
|
2017
Q4 | $36K | Hold |
370
| – | – | 0.02% | 117 |
|
|
2017
Q3 | $33K | Hold |
370
| – | – | 0.02% | 116 |
|
|
2017
Q2 | $27K | Hold |
370
| – | – | 0.02% | 126 |
|
|
2017
Q1 | $24K | Buy |
+370
| New | +$23.3K | 0.02% | 129 |
|
Other funds holding ABBV
Pacific Center for Financial Services's ABBV Position: Q2 2026 in Review
Pacific Center for Financial Services reduced its AbbVie (ABBV) stake by 8.7% in Q2 2026, selling an estimated $19.1K and leaving 935 shares worth $235K. The position accounts for 0.05% of the portfolio, ranked #86.
Pacific Center for Financial Services first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. The position peaked at $519K in Q3 2024. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Pacific Center for Financial Services held 935 shares of AbbVie worth $235K as of Q2 2026.
- Pacific Center for Financial Services sold 89 AbbVie shares in Q2 2026, an estimated $19.1K.
- AbbVie made up 0.05% of Pacific Center for Financial Services's portfolio in Q2 2026, its #86 holding.
- Pacific Center for Financial Services first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
- Pacific Center for Financial Services's AbbVie position peaked at $519K in Q3 2024.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.